Patents 5561037 - 5561165

 

 

Patent 5561037: Photographic elements containing magenta dye forming couplers and fade reducing compounds
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : RADIATION SENSITIVE PRODUCT : Identified radiation sensitive composition with color producing substance : Silver compound sensitizer : Coupler containing : And antifoggant or color stabilizer : Polymer of unsaturated ester or halide)

Patent 5561037: Photographic elements containing magenta dye forming couplers and fade reducing compounds
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : RADIATION SENSITIVE PRODUCT : Identified radiation sensitive composition with color producing substance : Silver compound sensitizer : Coupler containing : And antifoggant or color stabilizer : Polymer of unsaturated ester or halide)

Patent 5561038: Silver halide black and white photographic lightsensitive material
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : RADIATION SENSITIVE PRODUCT : Silver compound sensitizer containing : Silver compound having specified crystal form, habit, particle size or particle size distribution : Dye containing)

Patent 5561038: Silver halide black and white photographic lightsensitive material
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : RADIATION SENSITIVE PRODUCT : Silver compound sensitizer containing : Silver compound having specified crystal form, habit, particle size or particle size distribution : Dye containing)

Patent 5561039: Silver halide photographic light-sensitive material
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : RADIATION SENSITIVE PRODUCT : Silver compound sensitizer containing : Spectral sensitizing : Multiple sensitizers or supersensitizing : Inorganic material containing : Diazo)

Patent 5561039: Silver halide photographic light-sensitive material
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : RADIATION SENSITIVE PRODUCT : Silver compound sensitizer containing : Spectral sensitizing : Multiple sensitizers or supersensitizing : Inorganic material containing : Diazo)

Patent 5561040: Method for forming image
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : COLOR IMAGING PROCESS : Using identified radiation sensitive composition in the formation of color image : Silver compound sensitizer : And coupler : Identified magenta dye color : Substituted at coupling position with other than hydrogen)

Patent 5561040: Method for forming image
(RADIATION IMAGERY CHEMISTRY: PROCESS, COMPOSITION, OR PRODUCT THEREOF : COLOR IMAGING PROCESS : Using identified radiation sensitive composition in the formation of color image : Silver compound sensitizer : And coupler : Identified magenta dye color : Substituted at coupling position with other than hydrogen)

Patent 5561041: Nucleic acid mutation detection by analysis of sputum
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561041: Nucleic acid mutation detection by analysis of sputum
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561042: Diamine platinum naphthalimide complexes as antitumor agents
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561042: Diamine platinum naphthalimide complexes as antitumor agents
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561043: Self-assembling multimeric nucleic acid constructs
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561043: Self-assembling multimeric nucleic acid constructs
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561044: Detection of mycobacteria by multiplex strand displacement nucleic acid amplification
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561044: Detection of mycobacteria by multiplex strand displacement nucleic acid amplification
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)

Patent 5561045: Detection reagent, article, and immunoassay method
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving virus or bacteriophage :)

Patent 5561045: Detection reagent, article, and immunoassay method
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving virus or bacteriophage :)

Patent 5561046: Methods for the detection of acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)

Patent 5561046: Methods for the detection of acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)

Patent 5561047: Method of identifying effectors of integrin activation
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell :)

Patent 5561047: Method of identifying effectors of integrin activation
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell :)

Patent 5561049: Method for detecting antibodies
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)

Patent 5561049: Method for detecting antibodies
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)

Patent 5561050: Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Tumor cell or cancer cell :)

Patent 5561050: Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Tumor cell or cancer cell :)

Patent 5561051: Screen for inhibitors of chitinase
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving hydrolase : Involving creatine phosphokinase)

Patent 5561051: Screen for inhibitors of chitinase
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving hydrolase : Involving creatine phosphokinase)

Patent 5561052: Process for detecting oxidized lipids and process for forming oxidized lipids
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving oxidoreductase : Involving peptidase)

Patent 5561052: Process for detecting oxidized lipids and process for forming oxidized lipids
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving oxidoreductase : Involving peptidase)

Patent 5561053: Method for selecting high-expressing host cells
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)

Patent 5561053: Method for selecting high-expressing host cells
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)

Patent 5561054: Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, brugia malayi
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)

Patent 5561054: Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, brugia malayi
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)

Patent 5561055: Bacterial mass production of taxanes with Erwinia
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Aliphatic)

Patent 5561055: Bacterial mass production of taxanes with Erwinia
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Aliphatic)

Patent 5561056: Class of bifunctional additives for bioremediation of hydrocarbon contaminated soils and water
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Destruction of hazardous or toxic waste : Eimeria)

Patent 5561056: Class of bifunctional additives for bioremediation of hydrocarbon contaminated soils and water
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Destruction of hazardous or toxic waste : Eimeria)

Patent 5561057: Resolution of (RS)-ibuprofen by Candida antarctica catalyzed esterification with long chain alcohols while removing water
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Resolution of optical isomers or purification of organic compounds or composition containing same : Carbohydrate material recovered or purified)

Patent 5561057: Resolution of (RS)-ibuprofen by Candida antarctica catalyzed esterification with long chain alcohols while removing water
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Resolution of optical isomers or purification of organic compounds or composition containing same : Carbohydrate material recovered or purified)

Patent 5561058: Methods for coupled high temperatures reverse transcription and polymerase chain reactions
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Preparing nitrogen-containing saccharide : N-glycoside : Nucleotide : Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) : Acellular exponential or geometric amplification (e.g., PCR, etc.) :)

Patent 5561058: Methods for coupled high temperatures reverse transcription and polymerase chain reactions
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Preparing nitrogen-containing saccharide : N-glycoside : Nucleotide : Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) : Acellular exponential or geometric amplification (e.g., PCR, etc.) :)

Patent 5561059: Substrate bioavailability enhancing chemical mixture for use in bioremediation
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds : N-glycoside)

Patent 5561059: Substrate bioavailability enhancing chemical mixture for use in bioremediation
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds : N-glycoside)

Patent 5561060: Penicillium cultures capable of producing 10-membered ring lactones
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms : Oxygen as only ring hetero atom : Containing a hetero ring of at least seven ring members (e.g., zearalenone, macrocyclic lactones, etc.) : Nucleotide)

Patent 5561060: Penicillium cultures capable of producing 10-membered ring lactones
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms : Oxygen as only ring hetero atom : Containing a hetero ring of at least seven ring members (e.g., zearalenone, macrocyclic lactones, etc.) : Nucleotide)

Patent 5561062: Method of inhibiting viral reproduction using non-phospholipid, paucilamellar liposomes
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING : Inactivation or attenuation; producing viral subunits : By chemical treatment : Acting on amide linkage in cyclic amides (e.g., penicillinase, etc.) (3.5.2))

Patent 5561062: Method of inhibiting viral reproduction using non-phospholipid, paucilamellar liposomes
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING : Inactivation or attenuation; producing viral subunits : By chemical treatment : Acting on amide linkage in cyclic amides (e.g., penicillinase, etc.) (3.5.2))

Patent 5561063: Recombinant human cytomegalovirus containing foreign gene
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) : Separation of micro-organism from culture media)

Patent 5561063: Recombinant human cytomegalovirus containing foreign gene
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) : Separation of micro-organism from culture media)

Patent 5561064: Production of pharmaceutical-grade plasmid DNA
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) : Separation of micro-organism from culture media)

Patent 5561064: Production of pharmaceutical-grade plasmid DNA
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) : Separation of micro-organism from culture media)

Patent 5561065: Method for testing earth samples for contamination by organic contaminants
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : GEOCHEMICAL, GEOLOGICAL, OR GEOTHERMAL EXPLORATION : In situ testing : Milk or butter fat)

Patent 5561065: Method for testing earth samples for contamination by organic contaminants
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : GEOCHEMICAL, GEOLOGICAL, OR GEOTHERMAL EXPLORATION : In situ testing : Milk or butter fat)

Patent 5561066: Analysis of supercritical-extracted chelated metal ions from mixed organic-inorganic samples
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : METAL OR METAL CONTAINING : Glycosylated hemoglobin)

Patent 5561066: Analysis of supercritical-extracted chelated metal ions from mixed organic-inorganic samples
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : METAL OR METAL CONTAINING : Glycosylated hemoglobin)

Patent 5561067: Method of determining the severity of a lithogenesis condition and a composition of calculi forming salts
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : METAL OR METAL CONTAINING : Present in biological fluids (e.g., blood, urine, etc.) : With formation of a segmented stream)

Patent 5561067: Method of determining the severity of a lithogenesis condition and a composition of calculi forming salts
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : METAL OR METAL CONTAINING : Present in biological fluids (e.g., blood, urine, etc.) : With formation of a segmented stream)

Patent 5561068: Method and system for sampling and determining the presence of compounds
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : HYDROCARBON : Molecular oxygen)

Patent 5561068: Method and system for sampling and determining the presence of compounds
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : HYDROCARBON : Molecular oxygen)

Patent 5561069: Surface plasmon resonance detector having collector for eluted ligate
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS : Through a gel (e.g., Ouchterlony technique, etc.))

Patent 5561069: Surface plasmon resonance detector having collector for eluted ligate
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS : Through a gel (e.g., Ouchterlony technique, etc.))

Patent 5561070: Methods for preparing phospholipid coated particles and for eliciting or isolating antiphospholid antibodies and the particles
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS : Carrier is inorganic : Metal or metal coated : Magnetic :)

Patent 5561070: Methods for preparing phospholipid coated particles and for eliciting or isolating antiphospholid antibodies and the particles
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS : Carrier is inorganic : Metal or metal coated : Magnetic :)

Patent 5561071: DNA and DNA technology for the construction of networks to be used in chip construction and chip production (DNA-chips)
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Fluid growth from gaseous state combined with preceding diverse operation : Heat treatment)

Patent 5561071: DNA and DNA technology for the construction of networks to be used in chip construction and chip production (DNA-chips)
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Fluid growth from gaseous state combined with preceding diverse operation : Heat treatment)

Patent 5561072: Method for producing shallow junction in surface region of semiconductor substrate using implantation of plasma ions
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : INTRODUCTION OF CONDUCTIVITY MODIFYING DOPANT INTO SEMICONDUCTIVE MATERIAL : Plasma (e.g., glow discharge, etc.) : Heat treatment)

Patent 5561072: Method for producing shallow junction in surface region of semiconductor substrate using implantation of plasma ions
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : INTRODUCTION OF CONDUCTIVITY MODIFYING DOPANT INTO SEMICONDUCTIVE MATERIAL : Plasma (e.g., glow discharge, etc.) : Heat treatment)

Patent 5561073: Method of fabricating an isolation trench for analog bipolar devices in harsh environments
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : Having contacts formed by selective growth or deposition)

Patent 5561073: Method of fabricating an isolation trench for analog bipolar devices in harsh environments
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : Having contacts formed by selective growth or deposition)

Patent 5561074: Method for fabricating reverse-staggered thin-film transistor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Inverted transistor structure : Source-to-gate or drain-to-gate overlap : Having blooming suppression structure (e.g., antiblooming drain, etc.))

Patent 5561074: Method for fabricating reverse-staggered thin-film transistor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Inverted transistor structure : Source-to-gate or drain-to-gate overlap : Having blooming suppression structure (e.g., antiblooming drain, etc.))

Patent 5561075: Method of manufacturing an active matrix panel
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Including integrally formed optical element (e.g., reflective layer, luminescent material, contoured surface, etc.) : Liquid crystal component : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)

Patent 5561075: Method of manufacturing an active matrix panel
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Including integrally formed optical element (e.g., reflective layer, luminescent material, contoured surface, etc.) : Liquid crystal component : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)

Patent 5561076: Method of fabricating an isolation region for a semiconductor device using liquid phase deposition
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : Having contacts formed by selective growth or deposition)

Patent 5561076: Method of fabricating an isolation region for a semiconductor device using liquid phase deposition
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Total dielectric isolation : Having contacts formed by selective growth or deposition)

Patent 5561077: Dielectric element isolated semiconductor device and a method of manufacturing the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Stacked capacitor)

Patent 5561077: Dielectric element isolated semiconductor device and a method of manufacturing the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Stacked capacitor)

Patent 5561078: Method of fabrication of semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Multiple insulative layers in groove : Conformal insulator formation : Nonoxidized portions remaining in groove after oxidation)

Patent 5561078: Method of fabrication of semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Multiple insulative layers in groove : Conformal insulator formation : Nonoxidized portions remaining in groove after oxidation)

Patent 5561079: Stalagraphy
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Fluid growth from liquid combined with preceding diverse operation : Differential etching : Utilizing wave energy (e.g., laser, electron beam, etc.))

Patent 5561079: Stalagraphy
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Fluid growth from liquid combined with preceding diverse operation : Differential etching : Utilizing wave energy (e.g., laser, electron beam, etc.))

Patent 5561080: Semiconductor laser and method for fabricating the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Groove formation : Tapered etching : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)

Patent 5561080: Semiconductor laser and method for fabricating the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Groove formation : Tapered etching : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)

Patent 5561081: Method of forming a semiconductor device by activating regions with a laser light
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 5561081: Method of forming a semiconductor device by activating regions with a laser light
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 5561082: Method for forming an electrode and/or wiring layer by reducing copper oxide or silver oxide
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Stacked capacitor : Including doping of semiconductive region)

Patent 5561082: Method for forming an electrode and/or wiring layer by reducing copper oxide or silver oxide
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Stacked capacitor : Including doping of semiconductive region)

Patent 5561083: Method of making multilayered Al-alloy structure for metal conductors
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Plural layered electrode or conductor : At least one layer forms a diffusion barrier : Having noble group metal (i.e., silver (Ag), gold (Au), platinum (Pt), palladium (Pd), rhodium (Rh), ruthenium (Ru), iridium (Ir), osmium (Os), or alloy thereof))

Patent 5561083: Method of making multilayered Al-alloy structure for metal conductors
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Plural layered electrode or conductor : At least one layer forms a diffusion barrier : Having noble group metal (i.e., silver (Ag), gold (Au), platinum (Pt), palladium (Pd), rhodium (Rh), ruthenium (Ru), iridium (Ir), osmium (Os), or alloy thereof))

Patent 5561084: Method of making an interconnection structure of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : At least one metallization level formed of diverse conductive layers : By wire bonding)

Patent 5561084: Method of making an interconnection structure of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : At least one metallization level formed of diverse conductive layers : By wire bonding)

Patent 5561085: Structure for protecting air bridges on semiconductor chips from damage
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Insulative housing or support : And encapsulating)

Patent 5561085: Structure for protecting air bridges on semiconductor chips from damage
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Insulative housing or support : And encapsulating)

Patent 5561086: Techniques for mounting semiconductor dies in die-receiving areas having support structure having notches
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Direct application of electrical current)

Patent 5561086: Techniques for mounting semiconductor dies in die-receiving areas having support structure having notches
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Direct application of electrical current)

Patent 5561087: Method of forming a uniform thin film by cooling wafers during CVD
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Liquid phase etching)

Patent 5561087: Method of forming a uniform thin film by cooling wafers during CVD
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Liquid phase etching)

Patent 5561088: Heating method and manufacturing method for semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 5561088: Heating method and manufacturing method for semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Including recrystallization step : Including differential oxidation)

Patent 5561089: Glass-ceramic for information recording disk
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Devitrified glass-ceramics : Nonsilica and nonsilicate crystalline phase (e.g., spinel, barium titanate, etc.) : Divalent metal oxide aluminosilicate crystalline phase (e.g., anorthite, slagcerams, etc.))

Patent 5561089: Glass-ceramic for information recording disk
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Devitrified glass-ceramics : Nonsilica and nonsilicate crystalline phase (e.g., spinel, barium titanate, etc.) : Divalent metal oxide aluminosilicate crystalline phase (e.g., anorthite, slagcerams, etc.))

Patent 5561090: Dielectric ceramic composition for high frequencies and method for preparation of the same
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Titanate, zirconate, stannate, niobate, or tantalate or oxide of titanium, zirconium, tin, niobium, or tantalum containing (e.g., dielectrics, etc.) : Silica containing)

Patent 5561090: Dielectric ceramic composition for high frequencies and method for preparation of the same
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Titanate, zirconate, stannate, niobate, or tantalate or oxide of titanium, zirconium, tin, niobium, or tantalum containing (e.g., dielectrics, etc.) : Silica containing)

Patent 5561091: High activity polyethylene catalyst prepared from an alcohol and silicon tetrachloride
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Containing hydrides or organometallic of two or more different Component A metals : Magnesium containing :)

Patent 5561091: High activity polyethylene catalyst prepared from an alcohol and silicon tetrachloride
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Containing hydrides or organometallic of two or more different Component A metals : Magnesium containing :)

Patent 5561092: Metallocene catalysts with lewis acids and aluminum alkyls
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Component B metal is other than titanium or vanadium : Magnesium containing)

Patent 5561092: Metallocene catalysts with lewis acids and aluminum alkyls
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Component B metal is other than titanium or vanadium : Magnesium containing)

Patent 5561093: Catalyst useful for the polymerization of olefins
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Component B metal is other than titanium or vanadium : Magnesium containing)

Patent 5561093: Catalyst useful for the polymerization of olefins
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Component B metal is other than titanium or vanadium : Magnesium containing)

Patent 5561094: Dialkyl isocyanato tin alcoholate catalysts and dimers thereof
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : Organic compound including carbon-metal bond : And a third component C (i.e., an additive other than a saturated hydrocarbon or an aromatic hydrocarbon free of aliphatic or cycloaliphatic unsaturation))

Patent 5561094: Dialkyl isocyanato tin alcoholate catalysts and dimers thereof
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : Organic compound including carbon-metal bond : And a third component C (i.e., an additive other than a saturated hydrocarbon or an aromatic hydrocarbon free of aliphatic or cycloaliphatic unsaturation))

Patent 5561095: Supported lewis acid catalysts for hydrocarbon conversion reactions
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : With metal halide : Organic nitrogen containing)

Patent 5561095: Supported lewis acid catalysts for hydrocarbon conversion reactions
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : With metal halide : Organic nitrogen containing)

Patent 5561096: Catalytic system comprising a hydrogenation catalyst on a support and process for the hydrodechlorination of chlorofluorinated hydrocarbons
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VIII (i.e., iron or platinum group) : And Group I metal containing (i.e., alkali, Ag, Au or Cu) : Zinc containing)

Patent 5561096: Catalytic system comprising a hydrogenation catalyst on a support and process for the hydrodechlorination of chlorofluorinated hydrocarbons
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VIII (i.e., iron or platinum group) : And Group I metal containing (i.e., alkali, Ag, Au or Cu) : Zinc containing)

Patent 5561097: Method of controlling density of ligand coupled onto supports and products produced therefrom
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : SOLID SORBENT : Organic : Synthetic resin : And Group III metal containing (i.e., Sc, Y, Al, Ga, In or T1))

Patent 5561097: Method of controlling density of ligand coupled onto supports and products produced therefrom
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : SOLID SORBENT : Organic : Synthetic resin : And Group III metal containing (i.e., Sc, Y, Al, Ga, In or T1))

Patent 5561098: Transfer printing method and heat-melt transfer medium usable in the method
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)

Patent 5561098: Transfer printing method and heat-melt transfer medium usable in the method
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)

Patent 5561099: Alkylsiloxanes as adjuvants for agriculture
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Designated nonactive ingredient containing : Liquid carrier containing (e.g., water, hydrocarbon, etc.) : The resin is derived from ethylenically unsaturated monomer only (e.g., addition resins, natural rubbers, etc.))

Patent 5561099: Alkylsiloxanes as adjuvants for agriculture
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Designated nonactive ingredient containing : Liquid carrier containing (e.g., water, hydrocarbon, etc.) : The resin is derived from ethylenically unsaturated monomer only (e.g., addition resins, natural rubbers, etc.))

Patent 5561100: Pyrido-fused 4-oxo-4H-benzopyrans, their preparation and their use as antidotes
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Hetero ring containing active ingredient : Hetero ring is six-membered including nitrogen : Containing -C(=X)X- or -C(=X)NH-, wherein the X`s are the same or diverse chalcogens and substitution may be made for hydrogen only (e.g., phenoxyacetic acids, ureas, etc.))

Patent 5561100: Pyrido-fused 4-oxo-4H-benzopyrans, their preparation and their use as antidotes
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Hetero ring containing active ingredient : Hetero ring is six-membered including nitrogen : Containing -C(=X)X- or -C(=X)NH-, wherein the X`s are the same or diverse chalcogens and substitution may be made for hydrogen only (e.g., phenoxyacetic acids, ureas, etc.))

Patent 5561101: Substituted phthalides and heterocyclic phthalides
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Hetero ring is six-membered consisting of two nitrogens and four carbons (e.g., 1,4-diazines, etc.) : 1,3-diazines (including hydrogenated) : Chalcogen bonded directly to ring carbon of the diazine ring : Three or more ring hetero atoms in the polycyclo ring system)

Patent 5561101: Substituted phthalides and heterocyclic phthalides
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Hetero ring is six-membered consisting of two nitrogens and four carbons (e.g., 1,4-diazines, etc.) : 1,3-diazines (including hydrogenated) : Chalcogen bonded directly to ring carbon of the diazine ring : Three or more ring hetero atoms in the polycyclo ring system)

Patent 5561102: Inter-halogen-doped superconductive fullerenes
(SUPERCONDUCTOR TECHNOLOGY: APPARATUS, MATERIAL, PROCESS : HIGH TEMPERATURE (TC GREATER THAN 30 K) SUPERCONDUCTOR MATERIAL (I.E., ELEMENT, COMPOUND, OR COMPOSITION), PER SE : Halogen [i.e., fluorine (Fl), chlorine (Cl), bromine (Br), iodine (I), astatine (At)] containing :)

Patent 5561102: Inter-halogen-doped superconductive fullerenes
(SUPERCONDUCTOR TECHNOLOGY: APPARATUS, MATERIAL, PROCESS : HIGH TEMPERATURE (TC GREATER THAN 30 K) SUPERCONDUCTOR MATERIAL (I.E., ELEMENT, COMPOUND, OR COMPOSITION), PER SE : Halogen [i.e., fluorine (Fl), chlorine (Cl), bromine (Br), iodine (I), astatine (At)] containing :)

Patent 5561103: Functional fluid compositions having improved frictional and anti-oxidation properties
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic compound containing boron : Nitrogen containing (i.e., nitrogen and boron in the same compound) : Nitrogen containing)

Patent 5561103: Functional fluid compositions having improved frictional and anti-oxidation properties
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic compound containing boron : Nitrogen containing (i.e., nitrogen and boron in the same compound) : Nitrogen containing)

Patent 5561104: Hydraulic working oil composition for buffers
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic phosphorus compound, wherein the phosphorus is single bonded directly to chalcogen by nonionic bonding (e.g., phosphorus acids, esters, etc.) : A nitrogen compound is reacted with the phosphorus compound)

Patent 5561104: Hydraulic working oil composition for buffers
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic phosphorus compound, wherein the phosphorus is single bonded directly to chalcogen by nonionic bonding (e.g., phosphorus acids, esters, etc.) : A nitrogen compound is reacted with the phosphorus compound)

Patent 5561105: Chelating reagent containing photoresist stripper composition
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For printed or integrated electrical circuit, or semiconductor device : Azeotropic or azeotrope-like composition (e.g., for defluxing, etc.) : Nitrogen-containing component : With lime-soap dispersant)

Patent 5561105: Chelating reagent containing photoresist stripper composition
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For printed or integrated electrical circuit, or semiconductor device : Azeotropic or azeotrope-like composition (e.g., for defluxing, etc.) : Nitrogen-containing component : With lime-soap dispersant)

Patent 5561106: High foaming light duty liquid detergent composition comprising partially esterified ethoxylated polyhydric alcohol solubilizing agent
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : Six-membered alicyclic ring (e.g., menthol, etc.))

Patent 5561106: High foaming light duty liquid detergent composition comprising partially esterified ethoxylated polyhydric alcohol solubilizing agent
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : Six-membered alicyclic ring (e.g., menthol, etc.))

Patent 5561107: Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 5561107: Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 5561108: Preparation of .alpha..sub.1 -antichymotrypsin
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 5561108: Preparation of .alpha..sub.1 -antichymotrypsin
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 5561109: Method for the healing of wounds caused by corneal injury
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 5561109: Method for the healing of wounds caused by corneal injury
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)

Patent 5561110: Method for the treatment of the complications and pathology of diabetes
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 16 to 24 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561110: Method for the treatment of the complications and pathology of diabetes
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 16 to 24 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561111: Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 5 or 6 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561111: Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 5 or 6 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561112: Pseudopeptide isosteres of gly-asp and their use as antithrombic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561112: Pseudopeptide isosteres of gly-asp and their use as antithrombic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561113: New pseudopeptide compounds of neurokinins
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561113: New pseudopeptide compounds of neurokinins
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561114: Adsorbent for cellular fibronectin, a method for fractional purification of fibronectin and a method of hemocatharisis
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Produced by or extracted from animal tissue : Guanidine containing)

Patent 5561114: Adsorbent for cellular fibronectin, a method for fractional purification of fibronectin and a method of hemocatharisis
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Produced by or extracted from animal tissue : Guanidine containing)

Patent 5561115: Low temperature albumin fractionation using sodium caprylate as a partitioning agent
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Produced by or extracted from animal tissue : Guanidine containing)

Patent 5561115: Low temperature albumin fractionation using sodium caprylate as a partitioning agent
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Produced by or extracted from animal tissue : Guanidine containing)

Patent 5561116: Solid product containing propolis components, and preparation and uses thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : Produced by or extracted from animal tissue)

Patent 5561116: Solid product containing propolis components, and preparation and uses thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : Produced by or extracted from animal tissue)

Patent 5561117: Bridged bis-aryl carbinol derivatives, compositions and methods of use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561117: Bridged bis-aryl carbinol derivatives, compositions and methods of use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561118: Erythromycin compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring : The hetero ring has 8 or more ring carbons : The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.) :)

Patent 5561118: Erythromycin compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring : The hetero ring has 8 or more ring carbons : The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.) :)

Patent 5561119: Glycosylated prodrugs, their method of preparation and their uses
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings : Oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.) : The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.))

Patent 5561119: Glycosylated prodrugs, their method of preparation and their uses
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings : Oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.) : The hetero ring has 20 or more ring carbons (e.g., nystatin, etc.))

Patent 5561120: Method for treating HBV infections with L-2',3'-didehydro-dideoxy-5-fluorocytidine
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) : Phosphorus containing)

Patent 5561120: Method for treating HBV infections with L-2',3'-didehydro-dideoxy-5-fluorocytidine
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Pyrimidines (including hydrogenated) (e.g., cytosine, etc.) : Phosphorus containing)

Patent 5561121: Stable lyophilized thiotepa composition
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Nitrogen containing hetero ring : Hetero ring is three-membered consisting of one nitrogen and two carbons : Quinolinyl or isoquinolinyl (including hydrogenated))

Patent 5561121: Stable lyophilized thiotepa composition
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Nitrogen containing hetero ring : Hetero ring is three-membered consisting of one nitrogen and two carbons : Quinolinyl or isoquinolinyl (including hydrogenated))

Patent 5561122: Combretastatin A-4 prodrug
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Oxygen bonded directly to a carbon or hydrogen and wherein the oxygen is not bonded directly to phosphorus : The oxygen is bonded directly to a benzene ring : Sulfur bonded directly to a benzene ring)

Patent 5561122: Combretastatin A-4 prodrug
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Oxygen bonded directly to a carbon or hydrogen and wherein the oxygen is not bonded directly to phosphorus : The oxygen is bonded directly to a benzene ring : Sulfur bonded directly to a benzene ring)

Patent 5561123: Method of treating proliferative skin disorders with 19-nor-vitamin D compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI : Nitrogen containing (e.g., anilides, etc.))

Patent 5561123: Method of treating proliferative skin disorders with 19-nor-vitamin D compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI : Nitrogen containing (e.g., anilides, etc.))

Patent 5561124: 17-.alpha.-acyl steroids which inhibit 5-.alpha.-reductase
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : With a vitamin type active ingredient)

Patent 5561124: 17-.alpha.-acyl steroids which inhibit 5-.alpha.-reductase
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : With a vitamin type active ingredient)

Patent 5561125: Estradiol derivative and growth inhibiting composition thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system)

Patent 5561125: Estradiol derivative and growth inhibiting composition thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Cyclopentanohydrophenanthrene ring system DOAI : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system)

Patent 5561126: 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is four-membered and includes at least one ring nitrogen : Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen : Polycyclo ring system having the four-membered hetero ring as one of the cyclos : Bicyclo ring system having the four-membered hetero ring as one of the cyclos : Plural ring hetero atoms in the bicyclo ring system : Ring oxygen in the bicyclo ring system :)

Patent 5561126: 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is four-membered and includes at least one ring nitrogen : Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen : Polycyclo ring system having the four-membered hetero ring as one of the cyclos : Bicyclo ring system having the four-membered hetero ring as one of the cyclos : Plural ring hetero atoms in the bicyclo ring system : Ring oxygen in the bicyclo ring system :)

Patent 5561127: Muscarinic receptor ligands
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos : Tricyclo ring system having the seven-mmbered hetero ring as one of the cyclos : Nitrogen bonded directly to ring carbon of the seven-membered hetero ring : Ring chalcogen and ring nitrogen are in the 1,5-positions of the seven-membered hetero ring)

Patent 5561127: Muscarinic receptor ligands
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Polycyclo ring system which contains the seven-membered hetero ring as one of the cyclos : Tricyclo ring system having the seven-mmbered hetero ring as one of the cyclos : Nitrogen bonded directly to ring carbon of the seven-membered hetero ring : Ring chalcogen and ring nitrogen are in the 1,5-positions of the seven-membered hetero ring)

Patent 5561128: N-[(4-(hete roaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Tricyclo ring system having the seven-membered hetero ring a one of the cyclos : Two of the cyclos share at least three ring members (i.e., bridged))

Patent 5561128: N-[(4-(hete roaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Tricyclo ring system having the seven-membered hetero ring a one of the cyclos : Two of the cyclos share at least three ring members (i.e., bridged))

Patent 5561129: Methods of administering phenothiazines and/or acid addition salts thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.) : At least three cyclos in the polycyclo ring system : Phenothiazines (including hydrogenated) : With additional active ingredient)

Patent 5561129: Methods of administering phenothiazines and/or acid addition salts thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,3- and 1,4- benzothiazines, etc.) : At least three cyclos in the polycyclo ring system : Phenothiazines (including hydrogenated) : With additional active ingredient)

Patent 5561130: Azacyclic compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Ring nitrogen in the additional hetero ring : Bicyclo ring system having the additional hetero ring as one of the cyclos)

Patent 5561130: Azacyclic compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Ring nitrogen in the additional hetero ring : Bicyclo ring system having the additional hetero ring as one of the cyclos)

Patent 5561131: Defaunation method
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of three nitrogens and three carbon atoms : Nitrogen bonded directly to ring carbon of the hetero ring : Polycyclo ring system having the hetero ring as one of the cyclos)

Patent 5561131: Defaunation method
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of three nitrogens and three carbon atoms : Nitrogen bonded directly to ring carbon of the hetero ring : Polycyclo ring system having the hetero ring as one of the cyclos)

Patent 5561132: Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : 1,4-diazine as one of the cyclos : The chalcogen is bonded directly to two carbon atoms)

Patent 5561132: Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : 1,4-diazine as one of the cyclos : The chalcogen is bonded directly to two carbon atoms)

Patent 5561133: Thymidylate synthase inhibiting quinazolinones
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561133: Thymidylate synthase inhibiting quinazolinones
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561134: Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Exactly four ring nitrogens in the bicyclo ring system : Purine (including hydrogenated) : Additional hetero ring attached directly or indirectly to the purine ring system by nonionic bonding : The additional hetero ring consists of carbon and chalcogen as the only ring members : Chalcogen bonded directly to carbon of the hetero ring of the quinoline ring system)

Patent 5561134: Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Exactly four ring nitrogens in the bicyclo ring system : Purine (including hydrogenated) : Additional hetero ring attached directly or indirectly to the purine ring system by nonionic bonding : The additional hetero ring consists of carbon and chalcogen as the only ring members : Chalcogen bonded directly to carbon of the hetero ring of the quinoline ring system)

Patent 5561135: N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Nitrogen bonded directly to the 1,3-diazine at 2-position by a single bond : Chalcogen bonded directly to pyrimidine at 2-position)

Patent 5561135: N,N,N',N'-tetrasubstituted-1,2-ethanediamine derivative compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Nitrogen bonded directly to the 1,3-diazine at 2-position by a single bond : Chalcogen bonded directly to pyrimidine at 2-position)

Patent 5561136: Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Pentacyclo ring system having the six-membered hetero ring as one of the cyclos : Ring nitrogen in the pentacyclo ring system is shared by five-membered cyclo and six-membered cyclo (e.g., vincamine, etc.) : One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.))

Patent 5561136: Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Pentacyclo ring system having the six-membered hetero ring as one of the cyclos : Ring nitrogen in the pentacyclo ring system is shared by five-membered cyclo and six-membered cyclo (e.g., vincamine, etc.) : One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.))

Patent 5561137: Thio-heterocyclic macrolactam immunomodulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561137: Thio-heterocyclic macrolactam immunomodulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561138: Method of treating anemia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561138: Method of treating anemia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561139: Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561139: Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561140: Substituted alicyclic amine-containing macrocyclic immunomodulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561140: Substituted alicyclic amine-containing macrocyclic immunomodulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the tricyclo ring system : Ring carbon is shared by three of the cyclos)

Patent 5561141: MDR reversal agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Nitrogen, other than as nitro or nitroso, attached directly to the isoquinoline ring system by nonionic bonding)

Patent 5561141: MDR reversal agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Nitrogen, other than as nitro or nitroso, attached directly to the isoquinoline ring system by nonionic bonding)

Patent 5561142: Substituted sulfonamides as selective .beta..sub.3 agonists for the treatment of diabetes and obesity
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Chalcogen attached directly to the six-membered hetero ring by nonionic bonding : Three or more hetero atoms in the tricyclo ring system)

Patent 5561142: Substituted sulfonamides as selective .beta..sub.3 agonists for the treatment of diabetes and obesity
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Chalcogen attached directly to the six-membered hetero ring by nonionic bonding : Three or more hetero atoms in the tricyclo ring system)

Patent 5561143: Aliphatic amino bis-aryl squalene synthase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Chalcogen attached directly to the six-membered hetero ring by nonionic bonding : Three or more hetero atoms in the tricyclo ring system)

Patent 5561143: Aliphatic amino bis-aryl squalene synthase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Quinolines (including hydrogenated) : Chalcogen attached directly to the six-membered hetero ring by nonionic bonding : Three or more hetero atoms in the tricyclo ring system)

Patent 5561144: (+)-.alpha.-(2,3-dime thoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : Quinolines (including hydrogenated))

Patent 5561144: (+)-.alpha.-(2,3-dime thoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : Quinolines (including hydrogenated))

Patent 5561145: 4-aryloxy- and 4-arylthiopiperidine derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is a hetero ring : Polycyclo ring system is tricyclo-carbocyclic)

Patent 5561145: 4-aryloxy- and 4-arylthiopiperidine derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is a hetero ring : Polycyclo ring system is tricyclo-carbocyclic)

Patent 5561146: Modified guanidino and amidino thrombin inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561146: Modified guanidino and amidino thrombin inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)

Patent 5561147: Pyridine derivatives, their production and use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.) : Ring nitrogen in the polycyclo ring system)

Patent 5561147: Pyridine derivatives, their production and use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.) : Ring nitrogen in the polycyclo ring system)

Patent 5561148: Adhesion receptor antagonists III
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-oxazoles (including hydrogenated) : Chalcogen bonded directly to ring carbon of the oxazole ring : C=X bonded directly to the nitrogen which is bonded directly to the thiazole ring (X is chalcogen))

Patent 5561148: Adhesion receptor antagonists III
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-oxazoles (including hydrogenated) : Chalcogen bonded directly to ring carbon of the oxazole ring : C=X bonded directly to the nitrogen which is bonded directly to the thiazole ring (X is chalcogen))

Patent 5561149: Use of certain imidazol carbazols in treating stress-related manic-depressive disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-diazoles : Imidazoles : Additional hetero ring : Chalcogen or nitrogen bonded directly at 1-, 2- or 3-position of the diazole ring by nonionic bonding)

Patent 5561149: Use of certain imidazol carbazols in treating stress-related manic-depressive disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-diazoles : Imidazoles : Additional hetero ring : Chalcogen or nitrogen bonded directly at 1-, 2- or 3-position of the diazole ring by nonionic bonding)

Patent 5561150: Tricyclic pyrazole derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2-diazoles : Pyrazoles : Polycyclo ring system having the diazole ring as one of the cyclos)

Patent 5561150: Tricyclic pyrazole derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2-diazoles : Pyrazoles : Polycyclo ring system having the diazole ring as one of the cyclos)

Patent 5561151: Antipyretic and analgesic methods of using optically pure R-etodolac
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Tricyclo ring system having the five-membered hetero ring as one of the cyclos : At imidazole ring carbon)

Patent 5561151: Antipyretic and analgesic methods of using optically pure R-etodolac
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Tricyclo ring system having the five-membered hetero ring as one of the cyclos : At imidazole ring carbon)

Patent 5561152: Antidepressants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is five-membered : Plural ring oxygens in the hetero ring : Bicyclo ring system having the hetero ring as one of the cyclos (e.g., methylenedioxyphenyl group, etc.) : Nitrogen containing : C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen))

Patent 5561152: Antidepressants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is five-membered : Plural ring oxygens in the hetero ring : Bicyclo ring system having the hetero ring as one of the cyclos (e.g., methylenedioxyphenyl group, etc.) : Nitrogen containing : C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen))

Patent 5561153: Method of treating wrinkles using mucic acid or mucolactone
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is five-membered : Chalcogen bonded directly to the hetero ring : The nitrogen bonded directly to the hetero ring)

Patent 5561153: Method of treating wrinkles using mucic acid or mucolactone
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen containing hetero ring : The hetero ring is five-membered : Chalcogen bonded directly to the hetero ring : The nitrogen bonded directly to the hetero ring)

Patent 5561154: Treatment of acute urinary retention
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : ZC(=O)OY, wherein Z is an acyclic radical bonded to the C=O by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Ketone in Z radical)

Patent 5561154: Treatment of acute urinary retention
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ester DOAI : Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon : ZC(=O)OY, wherein Z is an acyclic radical bonded to the C=O by a carbon and Y is an organic radical bonded to the oxygen by a carbon : Ketone in Z radical)

Patent 5561155: Method of treating wrinkles using galacturonic acid or galacturonolactone
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561155: Method of treating wrinkles using galacturonic acid or galacturonolactone
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561156: Method of treating wrinkles using methyllactic acid
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561156: Method of treating wrinkles using methyllactic acid
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561157: Method for enhancing the therapeutic effect of a composition comprising hydroquinone and comprising same
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561157: Method for enhancing the therapeutic effect of a composition comprising hydroquinone and comprising same
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561158: Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561158: Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring in acid moiety)

Patent 5561159: Method of treating wrinkles using tropic acid
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring nonionically bonded : Carboxy or salt thereof only attached indirectly to the benzene ring : Polycarboxylic acid)

Patent 5561159: Method of treating wrinkles using tropic acid
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Benzene ring nonionically bonded : Carboxy or salt thereof only attached indirectly to the benzene ring : Polycarboxylic acid)

Patent 5561160: Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Polycarboxylic acid or salt thereof : Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.))

Patent 5561160: Formula and method for the prevention and treatment of hypercholesterolemia and cellular hyperproliferative disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI : Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.) : Polycarboxylic acid or salt thereof : Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.))

Patent 5561161: Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E) : R contains benzene ring : R contains benzene ring)

Patent 5561161: Methods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E) : R contains benzene ring : R contains benzene ring)

Patent 5561162: Fluoroalkenyl compounds and their use as pest repellents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E) : R is acyclic : Carbon to carbon unsaturation in R : The nitrogen in R is an amino nitrogen attached indirectly to a ring by acyclic bonding)

Patent 5561162: Fluoroalkenyl compounds and their use as pest repellents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E) : R is acyclic : Carbon to carbon unsaturation in R : The nitrogen in R is an amino nitrogen attached indirectly to a ring by acyclic bonding)

Patent 5561163: Treating hearing loss with deprenyl
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Benzene ring containing : Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain : The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only : Alkanol group only between the amino nitrogen and an ether oxygen which is bonded directly to the aryl ring or aryl ring system (i.e., aryloxy alkanol amines))

Patent 5561163: Treating hearing loss with deprenyl
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Benzene ring containing : Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain : The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only : Alkanol group only between the amino nitrogen and an ether oxygen which is bonded directly to the aryl ring or aryl ring system (i.e., aryloxy alkanol amines))

Patent 5561164: Method of treatng protozoal infections caused by microsporidia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ketone DOAI : Benzene ring containing : Plural rings : Polycyclo ring system : Bicyclo : Naphthyl ring system : C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen))

Patent 5561164: Method of treatng protozoal infections caused by microsporidia
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ketone DOAI : Benzene ring containing : Plural rings : Polycyclo ring system : Bicyclo : Naphthyl ring system : C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen))

Patent 5561165: Method for treating insulin resistance
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI : Acyclic : C-O-group containing : Tricyclo ring system)

 

Back to EveryPatent.com